New Pharmaceuticals market report from Datamonitor: "The Osteoporosis Market Forecast to 2021"
Boston, MA -- (SBWIRE) -- 03/18/2013 -- The seven major markets are characterized by an aging population and hence the incidence of osteoporosis will increase accordingly. The increase in patient numbers, however, will not lead to an increase in overall market value as the genericization of key bisphosphonate brands will cause heavy price erosion, leading to a negative growth trend that will continue throughout the forecast period.
- Interactive excel model accompanied by a pdf containing all Datamonitor's analysis and forecasts of this market to 2021.
- Forecast based on epidemiology data and primary research with 129 primary care physicians and specialists across the US, Japan, and 5EU.
- This forecast assesses the impact of generics, especially upon patent expiry of key bisphosphonate drugs such as Actonel, Boniva, and Reclast.
- Forecasts of the four new key products launching during the forecast period: Amgen's AMG-785, Radius' BA058, Pfizer's Aprela, and Merck's odanacatib.
View Full Report Details and Table of Contents
The growth in sales of newer products, such as Prolia (denosumab; Amgen) and soon-to-launch odanacatib (Merck & Co.) can only partly offset the market value decline caused by generic price erosion.
Odanacatib will become the top-grossing pipeline drug by the end of the forecast period.
Reasons to Get this Report
- Which brands will be affected by generic erosion the most; where and when will it take place?
- What is the impact of new pipeline drugs going to be and how successful can they become in a cost-constrained market?
About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.
Browse all Pharmaceuticals research reports at Fast Market Research
You may also be interested in these related reports:
- The Osteoporosis Market Outlook to 2021
- Osteoporosis Therapeutics - Pipeline Assessment and Market Forecasts to 2018
- Postmenopausal Osteoporosis Therapeutics - Pipeline Assessment and Market Forecasts to 2017
- Market Forecasts: Seasonal Influenza Vaccines - Broadened recommendations and increased awareness boost sales in the seasonal influenza vaccine market
- EpiCast Report: Osteoporosis - Epidemiology Forecast to 2022
- Market and Product Forecasts: Schizophrenia - The calm after the patent storm
- Market and Product Forecasts: Asthma - Premium products to offset loss to generics
- The Global UAV Market 2011-2021
- The Global Armored Vehicles and Counter IED Vehicles Market 2011-2021
- The Global Military Aircraft Market 2011-2021
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)